Heart failure: Mitochondrial dysfunction and oxidative stress in CHF

Nature Reviews Cardiology

Volumn 12, Issue 1, 2015, Pages 6-8

  Okonko, Darlington O ^a   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PLACEBO; REACTIVE OXYGEN METABOLITE; UBIDECARENONE; UBIQUINONE;

CARDIOVASCULAR MORTALITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY TRANSFER; ENERGY YIELD; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; ANALOGS AND DERIVATIVES; CHRONIC DISEASE; DRUG EFFECTS; HEART MITOCHONDRION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

CHRONIC DISEASE; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME; UBIQUINONE;

EID: 84927575168     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.189     Document Type: Short Survey

References (10)

1. Yancy, C. W. et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62, e147-e239 (2013).
2. Mortensen, S. A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure. Results from Q SYMBIO: a randomized double-blind trial. JACC Heart Fail. http:// dx.doi.org/10.1016/j.jchf.2014.06.008.
3. Burgoyne, J. R., Mongue Din, H., Eaton, P. & Shah, A. M. Redox signaling in cardiac physiology and pathology. Circ. Res. 111, 1091-1106 (2012).
4. Oka, T. et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485, 251-255 (2012).
5. Lygate, C. A. & Neubauer, S. Metabolic flux as a predictor of heart failure prognosis. Circ. Res. 114, 1228-1230 (2014).
6. Hare, J. M. et al. Impact of oxypurinol in patients with symptomatic heart failure. Results from the OPT-CHF study. J. Am. Coll. Cardiol. 51, 2301-2309 (2008).
7. Ernster, L. & Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271, 195-204 (1995).
8. McMurray, J. J. V. et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J. Am. Coll. Cardiol. 56, 1196-1204 (2010).
9. O'Connor, C. M. et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF ACTION randomized controlled trial. JAMA 301, 1439-1450 (2009).
10. Dai, D. F. et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J. Am. Coll. Cardiol. 58, 73-82 (2011).